Literature DB >> 2662048

Hypocomplementemic proliferative glomerulonephritis with C3 nephritic-factor-like activity in multiple myeloma.

E Bourke1, W G Campbell, M Piper, I J Check.   

Abstract

Advanced renal failure, nephrotic-range proteinuria due to proliferative glomerulonephritis and multiple myeloma with circulating IgG2 lambda and free lambda light-chain paraproteins occurred in a 31-year-old male. Commonly established causes of renal failure in multiple myeloma were excluded. Immunofluorescence revealed heavy granular glomerular deposition of C3. Serum C3 was decreased, and C3c was increased. C3 nephritic-factor (C3 NeF)-like activity was demonstrated in the serum. Plasmapheresis and chemotherapy resulted in a decrease in paraprotein concentration up to 90%, a decrease in C3 NeF-like activity to negligible, normal serum complement levels and a marked improvement in both renal function and proteinuria. With reference to the literature, the possibility of a syndrome of paraproteinemia, C3 NeF-like activity and glomerulonephritis is forwarded.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662048     DOI: 10.1159/000185648

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy.

Authors:  Camilla Aakjær Andersen; Niels Marcussen; Jon Waarst Gregersen
Journal:  Clin Kidney J       Date:  2013-11-04

Review 2.  Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.

Authors:  Michael Rudnicki
Journal:  Biomed Res Int       Date:  2017-05-09       Impact factor: 3.411

Review 3.  C3 glomerulonephritis in multiple myeloma: A case report and literature review.

Authors:  Guang Yin; Zhen Cheng; Cai-Hong Zeng; Zhi-Hong Liu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

4.  C3 glomerulonephritis along with light chain proximal tubulopathy without crystal deposits in multiple myeloma: a case report.

Authors:  Junhui Xu; Xiaojuan Yu; Suxia Wang; Miao Yan; Mangju Wang; Jinping Ou; Lihong Wang; Huihui Liu; Xinan Cen
Journal:  World J Surg Oncol       Date:  2021-01-22       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.